Banner
  • Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Why I'm investing in a Losing Stock

Article

Going against the grain is difficult. But it is nice to back a loser, especially if it ends up a winner.

Going against the grain is difficult. Especially, when market gurus make public statements that caution individual investors not to do what I’m up to. Still, it is happening.

The lonely exchange-traded fund (ETF) I am going to buy has a miserable track record. While the S&P 500 charged upward 40% in the last 5 years, according to the chart below from Yahoo.com, this underdog dropped 20%. It is the IPath Dow Jones-UBS commodity Index Total Return ETF, known as DJP.

That is an impressive lack of performance compared to the general market. It wouldn’t make many mothers happy.

While the S&P in green surged after our recent financial fiasco, DJP in blue dropped 20%. Chart courtesy Yahoo.com.

DJP “is designed to provide investors with exposure to the Dow Jones-UBS Commodity Index Total Return,” according to its marketing. It is unleveraged and invests in “futures contracts on physical communities.”

The top 5 holdings include gold, natural gas, crude oil, corn, and copper. Its expense ratio is 0.75%—high in my mind. But, it does provide rolling index rebalancing annually even though it is a passive index.

Now, this is why DJP may turn around.

First, there is always reversion to the mean. This is what I’m counting on. Also, while other ETFs, mutual funds, and stocks have increased in value, DJP hasn’t. In fact, it has dropped compared to them. Additionally, for those who are dividend shy due to taxes that must be paid in a taxable account, this ETF has no dividend at all. And, lastly, the 200-day moving average is positive. DJP bounced above it early this year and had continued in this manner.

If DJP had a mother, this surely would make her joyous.

DJP moved above its 200-day average early this year and has continued above it. Chart courtesy Yahoo.com.

For the record, I am not a fan of technical analysis, which is what the 200-day moving average represents. My primary motivation in my decision is that the ETF will see a reversion to its mean sooner or later. Plus, there are few options to buy what could be a winner at a modest price. So, for those with money, this might be considered for a small part of a total portfolio.

Besides it is nice to back a loser—especially if it wins.

This information and content is offered for informative and educational purposes only. MyMoneyMD, LLC, is not acting as a Registered Investment Advisor, Investment Counsel, Tax Advisor or Legal Advisor.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice